Results of using the neuroprotective drug Cellex in non-traumatic intracranial hemorrhage
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use of this drug in hemorrhagic stroke has been studie...
Autori principali: | Kh. D. Mongush, A. V. Kyrgys, A. A. Sedip, A. E. Shyyrap, A. B. Ondar, M. G. Zhestikova |
---|---|
Natura: | Articolo |
Lingua: | Russian |
Pubblicazione: |
Remedium Group LLC
2022-03-01
|
Serie: | Медицинский совет |
Soggetti: | |
Accesso online: | https://www.med-sovet.pro/jour/article/view/6755 |
Documenti analoghi
Documenti analoghi
-
Efficacy of Cellex in patients with mild cognitive impairment
di: B. A. Abusueva, et al.
Pubblicazione: (2019-04-01) -
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE
di: G. N. BELSKAYA, et al.
Pubblicazione: (2016-12-01) -
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice
di: Fei Wang, et al.
Pubblicazione: (2022-06-01) -
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
di: O. D. Ostroumova, et al.
Pubblicazione: (2022-12-01) -
Acute albumin administration as therapy for intracerebral hemorrhage: A literature review
di: Yirong Cao, et al.
Pubblicazione: (2024-01-01)